SeptRx's Series A Round

SeptRx raised a round of funding on June 06, 2011. Investors include Confluent Medical Technologies.

SeptRx is a cardiovascular medical device company that is developing a platform for the percutaneous transcatheter closure of a heart defect known as patent foramen ovale.…

Articles about SeptRx's Series A Round: